If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKooth Plc Regulatory News (KOO)

Share Price Information for Kooth Plc (KOO)

Share Price is delayed by 15 minutes
Get Live Data
163.50    0.00 (0.00%)
Bid:
158.00
Ask:
164.00
Spread: 6.00 (3.797%)
Market Cap: £58.40m
KOO Live PriceLast checked at - London Stock Exchange

Intraday Kooth Plc Share Chart

Holdings in the Company

28 Apr 2021 07:00

RNS Number : 7915W
Kooth PLC
28 April 2021
 

Kooth plc

("Kooth" or the "Company" or the "Group")

Holdings in the Company

The Board of Kooth was yesterday informed of the following transaction in ordinary shares of £0.05 each ("Ordinary Shares") in the capital of the Company: Root Capital Fund II Limited Partnership, trading under the name ScaleUp Capital, classified as a Person Closely Associated with Mr. Simon Philips, a Non-Executive Director of the Company, sold 3,000,000 Ordinary Shares yesterday. ScaleUp Capital's interest is now 13,609,873 Ordinary Shares, representing 41.2% of the Company's issued share capital.

 

This transaction, which was undertaken yesterday in response to market demand, was completed at a price of 350 pence per Ordinary Share.

 

Prior to undertaking this transaction, ScaleUp Capital obtained the consent of the Company and Panmure Gordon (UK) Limited to the lifting of the lock-in agreement ("the Agreement") entered into at the time of the Company's IPO in respect of the Ordinary Shares sold. In accordance with the Agreement, ScaleUp Capital has agreed not to sell any further Ordinary Shares until 2 September this year. The orderly market period then continues until 2 September 2022.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

- Ends -

 

Kooth plc

Tim Barker, CEO

Sanjay Jawa, CFO

investorrelations@kooth.com 

Panmure Gordon, Nominated Adviser and sole Broker

Corporate Finance:

Dominic Morley, Nicholas Harland, Sandy Clark

Corporate Broking:

Erik Anderson

+44 (0) 20 7886 2500

FTI Consulting

Jamie Ricketts / Alex Shaw / Usama Ali 

kooth@fticonsulting.com

 

Notes to Editors

About Kooth

Kooth is one of the UK's leading digital mental health platforms, set up to provide accessible and safe spaces for everyone to achieve better mental health. The Company's online platform is clinically robust and accredited to provide a range of therapeutic support and interventions. All services are predicated on easy access to make early intervention and prevention a reality. 

Kooth offers three services: 

· Kooth is commissioned in 85% of the NHS's clinical commissioning group areas across the country. It is a fully safeguarded and pre-moderated community with a library of peer and professional created content, alongside access to experienced online counsellors. There are no thresholds for support and no waiting lists. Currently, Kooth sees over 3,000 logins a day. 

· Kooth Adult operates across distinct locations and serves specific cohorts, including parents, teachers, victims of crime and those who have suffered from or continue to experience domestic violence.

· Kooth Work is a corporate service, aimed specifically at employers to support the wellbeing of their employees, providing confidential and anonymous access to a wellbeing community, counselling, content and self-help tools. Kooth Work provides valuable, anonymous insights into the wellbeing of the workforce so that employers can identify specific areas of improvement for their wellbeing strategy.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated with them.

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Kooth plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

x

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Root Capital Fund II

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

27/04/2021

6. Date on which issuer notified (DD/MM/YYYY):

27/04/2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

41.2%

N/A

41.2%

33,055,776

Position of previous notification (if

applicable)

N/A

N/A

N/A

·

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BMCZLK30

13,609,873

41.2%

SUBTOTAL 8. A

13,609,873

41.2%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

·

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Root Capital Fund II

41.2%

41.2%

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

·

Place of completion

LONDON, UK

Date of completion

27/04/2021

·

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLDKOBDKBKBFQB
Date   Source Headline
26th Jun 20262:38 pmRNSTransfer of Treasury Shares & Exercise of Options
23rd Jun 20263:01 pmRNSResult of 2026 Annual General Meeting
19th May 20267:00 amRNS2025 Annual Report and Notice of 2026 AGM
19th May 20267:00 amRNSDirectorate Change
20th Apr 20267:00 amRNS-R2025 Impact Report Shows Soluna's Continued Growth
8th Apr 20267:00 amRNS2025 Full Year Results
19th Mar 20267:00 amRNSNotice of Full Year Results
12th Mar 20269:19 amRNSTransfer of Treasury Shares & Exercise of Options
2nd Mar 202610:57 amRNSTransfer of Treasury Shares & Exercise of Options
2nd Mar 20267:00 amRNSBlock Listing Six Monthly Return
11th Feb 20265:51 pmRNSAwards under LTIP and PDMR dealing
2nd Feb 202612:48 pmRNSTransfer of Treasury Shares & Exercise of Options
28th Jan 20267:00 amRNSTrading Update
22nd Jan 20267:05 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNS$2.6m contract win with new US State
17th Dec 202510:02 amRNSTransfer of Treasury Shares & Exercise of Options
4th Dec 20253:26 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNS-RKooth Acquires US Telehealth Platform
11th Nov 20257:00 amRNSTransfer of Treasury Shares & Exercise of Options
10th Oct 20252:30 pmRNSHolding(s) in Company
2nd Oct 20257:00 amRNSKooth renews New Jersey contract
24th Sep 20253:55 pmRNSHolding(s) in Company
23rd Sep 20257:00 amRNSUnaudited Half Year Results
4th Sep 20257:00 amRNSTransfer of Treasury Shares & Exercise of Options
29th Aug 20257:00 amRNSBlock Listing Six Monthly Return
8th Aug 20257:00 amRNSAppointment of Joint Corporate Broker
1st Aug 20257:00 amRNSTransfer of Treasury Shares & Exercise of Options
28th Jul 20257:00 amRNSHalf Year Trading and Operational Update
1st Jul 20257:00 amRNSKooth welcomes report on California Soluna data
27th Jun 20253:51 pmRNSHolding(s) in Company
24th Jun 20251:12 pmRNSResult of 2025 Annual General Meeting
3rd Jun 20259:32 amRNSHolding(s) in Company
23rd May 20254:06 pmRNSAwards - Long Term Incentive Plan and PDMR dealing
14th May 20257:00 amRNSAnnual Financial Report
15th Apr 20257:00 amRNSFull Year Results
31st Mar 20251:00 pmRNSHolding in Company
28th Feb 20257:00 amRNSBlock Listing Six Monthly Return
13th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20255:53 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.